A re-evaluated role for cyclic AMP in uterine relaxation. Differential effect of isoproterenol and forskolin
- PMID: 3020232
A re-evaluated role for cyclic AMP in uterine relaxation. Differential effect of isoproterenol and forskolin
Abstract
Our previous observations suggested that beta adrenergic-mediated relaxation of the rat myometrium could not be ascribed solely to cyclic AMP. The present study examines the relationships between relaxation and cyclic AMP accumulation in the myometrium in response to isoproterenol, forskolin and the combination of both. The diterpene enhanced cyclic AMP generation and potentiated the rises in cyclic AMP due to isoproterenol and prostaglandin (PG) E2. Isoproterenol-induced relaxation of a carbachol-contracted myometrium was associated with modest increments in cyclic AMP (6-12 pmol/mg of protein) in contrast to forskolin whose relaxing effect could be expressed only when associated with large increases in cyclic AMP (80-180 pmol/mg of protein). PGE2, although elevating cyclic AMP to the same extent as isoproterenol, caused contractions which were antagonized by isoproterenol and forskolin, respectively, associated with low and high cyclic AMP concentrations. Both PGE2 and forskolin, by virtue of their stimulatory effect on cyclic AMP generation, enhanced the efficiency of isoproterenol to cause relaxation. Likewise, the greater efficacy of forskolin to relax a PGE2- as opposed to a carbachol-contracted myometrium, was ascribed to its potentiated cyclic AMP response when combined with PGE2. It is proposed that the beta adrenoceptor-linked relaxation results from the concerted effects of both a cyclic AMP-dependent (sensitive to low cyclic AMP) and a cyclic AMP-independent process; the latter is postulated to operate at the membrane level with an ultimate reduction in cytosolic Ca++. On the other hand, cyclic AMP, provided it reached a critical concentration essential to mediate intracellular Ca++ sequestration, would be the sole determinant for forskolin-elicited relaxation.
Similar articles
-
Forskolin modulates cyclic AMP generation in the rat myometrium. Interactions with isoproterenol and prostaglandins E2 and I2.J Cyclic Nucleotide Protein Phosphor Res. 1985;10(3):213-27. J Cyclic Nucleotide Protein Phosphor Res. 1985. PMID: 2991348 Review.
-
Heterologous regulations of cAMP responses in pregnant rat myometrium. Evolution from a stimulatory to an inhibitory prostaglandin E2 and prostacyclin effect.Mol Pharmacol. 1987 Aug;32(1):249-57. Mol Pharmacol. 1987. PMID: 3039339
-
Ca(++)-independent relaxation mediated by beta adrenoceptor in Ca(++)-independent contraction of uterine smooth muscle.J Pharmacol Exp Ther. 1993 Jul;266(1):367-73. J Pharmacol Exp Ther. 1993. PMID: 8101221
-
Estrogen reduces beta-adrenoceptor-mediated cAMP production and the concentration of the guanyl nucleotide-regulatory protein, Gs, in rabbit myometrium.Mol Pharmacol. 1988 Apr;33(4):389-95. Mol Pharmacol. 1988. PMID: 2833685
-
Selective interactions of cyclooxygenase and lipoxygenase metabolites with the cyclic GMP systems in the myometrium.Adv Cyclic Nucleotide Protein Phosphorylation Res. 1984;17:639-49. Adv Cyclic Nucleotide Protein Phosphorylation Res. 1984. PMID: 6145335 Review. No abstract available.
Cited by
-
The lack of involvement of cyclic nucleotides in the smooth muscle relaxant action of BRL 34915.Br J Pharmacol. 1988 Aug;94(4):1189-97. doi: 10.1111/j.1476-5381.1988.tb11638.x. Br J Pharmacol. 1988. PMID: 2850057 Free PMC article.
-
Effects of forskolin on contractile responses and protein phosphorylation in the isolated perfused rat heart.Biochem J. 1987 Sep 15;246(3):687-95. doi: 10.1042/bj2460687. Biochem J. 1987. PMID: 2825646 Free PMC article.
-
Prostaglandins and muscarinic agonists induce cyclic AMP attenuation by two distinct mechanisms in the pregnant-rat myometrium. Interaction between cyclic AMP and Ca2+ signals.Biochem J. 1990 Nov 1;271(3):667-73. doi: 10.1042/bj2710667. Biochem J. 1990. PMID: 1700899 Free PMC article.
-
Hormonal and local regulation of uterine activity during parturition: Part II--The prostaglandin and adrenergic systems.J Endocrinol Invest. 1994 Oct;17(9):757-70. doi: 10.1007/BF03347772. J Endocrinol Invest. 1994. PMID: 7868821 Review. No abstract available.